BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20360940)

  • 21. Active sites of human MEPE-ASARM regulating bone matrix mineralization.
    Minamizaki T; Sakurai K; Hayashi I; Toshishige M; Yoshioka H; Kozai K; Yoshiko Y
    Mol Cell Endocrinol; 2020 Nov; 517():110931. PubMed ID: 32712387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
    Wang F; Dong X; Xiu P; Zhong J; Wei H; Xu Z; Li T; Liu F; Sun X; Li J
    Oncol Rep; 2015 Feb; 33(2):675-84. PubMed ID: 25483829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
    Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
    Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells.
    Nyormoi O; Mills L; Bar-Eli M
    Cell Death Differ; 2003 May; 10(5):558-69. PubMed ID: 12728254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM‑19.
    Li M; Li Z; Li J; Jin L; Jin C; Han C; Ji X; Sun F
    Mol Med Rep; 2015 Dec; 12(6):8185-92. PubMed ID: 26458285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.
    Zhang Z; Hou L; Feng L; Huang S; Luo M; Shao S; Zhang X; Gu S; Zhao X
    Tumour Biol; 2015 Sep; 36(10):8167-75. PubMed ID: 25990455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional domains on elastin and microfibril-associated glycoprotein involved in elastic fibre assembly.
    Brown-Augsburger P; Broekelmann T; Rosenbloom J; Mecham RP
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):149-55. PubMed ID: 8761465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An N-linked carbohydrate-containing extracellular matrix determinant plays a key role in sea urchin gastrulation.
    Ingersoll EP; Ettensohn CA
    Dev Biol; 1994 Jun; 163(2):351-66. PubMed ID: 7515360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel proapoptotic gene PANO encodes a post-translational modulator of the tumor suppressor p14ARF.
    Watari A; Li Y; Higashiyama S; Yutsudo M
    Exp Cell Res; 2012 Feb; 318(3):187-95. PubMed ID: 22094112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.
    Zang ZJ; Sim KG; Cheong JK; Yang CM; Yap CS; Hsu SI
    Cancer Biol Ther; 2007 May; 6(5):712-8. PubMed ID: 17507796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
    Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A C-terminal fragment BIGH3 protein with an RGDRGD motif inhibits corneal neovascularization in vitro and in vivo.
    Ge H; Tian P; Guan L; Yin X; Liu H; Xiao N; Xiong Y; Luo X; Sun Y; Qi D; Ni S; Liu P
    Exp Eye Res; 2013 Jul; 112():10-20. PubMed ID: 23562678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
    Huang GM; Sun Y; Ge X; Wan X; Li CB
    World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
    Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.